Tauriga Sciences Inc (fka TAUG)

[Johnny_C]

I would wait till 4th quarter before passing judgment on AV101. Nothing has changed except the stock price due to an over reaction based on a statistically meaningless trial involving only 19 patients the had an average of 9 yrs of chronic depression. It appears that no drug has been effective. Furthermore, that study started in 2015 and took 3 yrs to even enroll those patients and the study was a mono therapy as opposed to an adjunctive treatment. AV101 is still fast tracked for pain and has 2 other drugs in the pipeline, both nasal drugs.

This lays it out fairly well


https://maxim.bluematrix.com/sellside/EmailDocViewer?encrypt=fea5bc64-af05-423d-9493-24f68d605c6e&mime=pdf&co=maxim&id=[e-mail]&source=mail


The conference was about TAUGs products and from what I could see there was plenty of interest by funds in throwing money at CBD companies. Just a guess, but I think the balance sheet will be fine